“Great vision without great people is irrelevant."
Jim Collins
Co-Founder and CEO
Chief Scientific Officer
Chief Commercial Officer
Chief Technology Officer
Chief Medical Officer
VP, Quality and Operations
VP, Clinical Operations
Sr. Director of Finance and Business Development
Director of Research
Director of Program Management
Director of Engineering & Transfer
Director of Operations
Associate Director, Preclinical Studies
Clinical Trial Manager
Sr. Design Engineer
Operations Manager
R&D Engineer
R&D Engineer
Executive Assistant to CEO
We are always looking for hard-working, passionate individuals who are excited to bring new contraceptive options to the world. If you enjoy working in small teams and solving difficult problems, you'd be a great fit for Contraline.
We are always looking for hard-working, passionate individuals who are excited to bring new contraceptive options to the world. If you enjoy working in small teams and solving difficult problems, you'd be a great fit for Contraline.
Executive with over 30 years of experience leading companies through approval and commercialization.
Founder and Managing Partner at MBX Capital, an early-stage healthcare venture fund.
Co-Founder and CEO of Contraline
Professor and Head of the Department of Urology at the University of Illinois at Chicago; co-editor in chief of Fertility and Sterility.
Board-certified urologist and Associate Professor of Urology at UC Irvine, specializing in male reproductive medicine.
Professor of Urology at the Medical College of Wisconsin and fellowship-trained specialist in male infertility.
Associate Professor of Agricultural & Biological Engineering, Materials Engineering, and Biomedical Engineering at Purdue University.
1948-2016
Contraline is deeply rooted in Dr. John Herr's essence. Dr. Herr was a visionary, a scientist, and an entrepreneur at the forefront of reproductive biology. Contraline continues in the legacy of our co-founder by working relentlessly to develop new reproductive health technologies. Learn more about John here.